A small molecule that interferes with HIV Vif promotes the antiviral activity of the human protein APOBEC3G.
References
Sheehy, A.M., Gaddis, N.C., Choi, J.D. & Malim, M.H. Nature 418, 646–650 (2002).
Haché, G., Shindo, K., Albin, J.S. & Harris, R.S. Curr. Biol. 18, 819–824 (2008).
Nathans, R. . Nat. Biotechnol. 26, 1187–1192 (2008).
Yu, X. et al. Science 302, 1056–1060 (2003).
Harris, R.S. et al. Cell 113, 803–809 (2003).
Mangeat, B. et al. Nature 424, 99–103 (2003).
Zhang, H. et al. Nature 424, 94–98 (2003).
Xiao, Z. et al. FASEB J. 21, 217–222 (2007).
Mehle, A. et al. J. Virol. 81, 13235–13241 (2007).
Loeb, L.A. et al. Proc. Natl. Acad. Sci. USA 96, 1492–1497 (1999).
Harris, R.S., Petersen-Mahrt, S.K. & Neuberger, M.S. Mol. Cell 10, 1247–1253 (2002).
Schumacher, A.J., Nissley, D.V. & Harris, R.S. Proc. Natl. Acad. Sci. USA 102, 9854–9859 (2005).
Mulder, L.C., Harari, A. & Simon, V. Proc. Natl. Acad. Sci. USA 105, 5501–5506 (2008).
Simon, V. et al. PLoS Pathog. 1, e6 (2005).
Rose, K.M., Marin, M., Kozak, S.L. & Kabat, D. J. Biol. Chem. 279, 41744–41749 (2004).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Harris, R. Enhancing immunity to HIV through APOBEC. Nat Biotechnol 26, 1089–1090 (2008). https://doi.org/10.1038/nbt1008-1089
Issue Date:
DOI: https://doi.org/10.1038/nbt1008-1089
- Springer Nature America, Inc.
This article is cited by
-
Evidence Supporting That C-to-U RNA Editing Is the Major Force That Drives SARS-CoV-2 Evolution
Journal of Molecular Evolution (2023)
-
Endogenous APOBEC3B overexpression characterizes HPV-positive and HPV-negative oral epithelial dysplasias and head and neck cancers
Modern Pathology (2021)
-
Evasion of adaptive immunity by HIV through the action of host APOBEC3G/F enzymes
AIDS Research and Therapy (2017)
-
Damage control: how HIV survives the editor APOBEC3G
Nature Immunology (2011)